Literature DB >> 28616262

RASSF1A methylation, YAP1 activation and metastasis: a new role for an old foe in lung cancer.

Min Hee Oh1,2, William W Lockwood1,2,3.   

Abstract

Entities:  

Year:  2017        PMID： 28616262      PMCID： PMC5465109          DOI： 10.21037/jtd.2017.04.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1.

Authors:  Sara Ortiz-Vega; Andrei Khokhlatchev; Maria Nedwidek; Xian-feng Zhang; Reinhard Dammann; Gerd P Pfeifer; Joseph Avruch
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

2.  KRAS and YAP1 converge to regulate EMT and tumor survival.

Authors:  Diane D Shao; Wen Xue; Elsa B Krall; Arjun Bhutkar; Federica Piccioni; Xiaoxing Wang; Anna C Schinzel; Sabina Sood; Joseph Rosenbluh; Jong W Kim; Yaara Zwang; Thomas M Roberts; David E Root; Tyler Jacks; William C Hahn
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

3.  RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway.

Authors:  Fatéméh Dubois; Maureen Keller; Olivier Calvayrac; Fabrice Soncin; Lily Hoa; Alexander Hergovich; Maria-Carla Parrini; Julien Mazières; Mélissa Vaisse-Lesteven; Jacques Camonis; Guénaëlle Levallet; Gérard Zalcman
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

4.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Authors:  R Dammann; C Li; J H Yoon; P L Chin; S Bates; G P Pfeifer
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

5.  Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.

Authors:  Mitsuo Sato; Jill E Larsen; Woochang Lee; Han Sun; David S Shames; Maithili P Dalvi; Ruben D Ramirez; Hao Tang; John Michael DiMaio; Boning Gao; Yang Xie; Ignacio I Wistuba; Adi F Gazdar; Jerry W Shay; John D Minna
Journal:  Mol Cancer Res       Date:  2013-02-28       Impact factor: 5.852

6.  Mechanistic insight into GPCR-mediated activation of the microtubule-associated RhoA exchange factor GEF-H1.

Authors:  David Meiri; Christopher B Marshall; Daphna Mokady; Jose LaRose; Michael Mullin; Anne-Claude Gingras; Mitsuhiko Ikura; Robert Rottapel
Journal:  Nat Commun       Date:  2014-09-11       Impact factor: 14.919

7.  Comprehensive molecular profiling of lung adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962
  7 in total
  2 in total

1.  TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).

Authors:  Shuai Ye; Ying Liu; Ashley M Fuller; Rohan Katti; Gabrielle E Ciotti; Susan Chor; Md Zahidul Alam; Samir Devalaraja; Kristin Lorent; Kristy Weber; Malay Haldar; Michael A Pack; T S Karin Eisinger-Mathason
Journal:  Mol Cancer Res       Date:  2020-01-27       Impact factor: 5.852

2.  Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India).

Authors:  Naseer Ue Din Shah; Md Niamat Ali; Bashir A Ganai; Syed Mudassar; Mosin Saleem Khan; Jasbir Kour; Ajaz Ahmad Waza; Malik Tariq Rasool; Aabid Maqbool Lone
Journal:  Heliyon       Date:  2020-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.